Friday, October 19, 2012

Health - Google News: Jetrea Gets FDA Nod for Macular Adhesion - MedPage Today

Health - Google News
Google News
Jetrea Gets FDA Nod for Macular Adhesion - MedPage Today
Oct 19th 2012, 16:01


RTT News

Jetrea Gets FDA Nod for Macular Adhesion
MedPage Today
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion. Symptomatic vitreomacular adhesion is a condition where the jelly around the macula -- called vitreous -- moves away ...
ThromboGenics says main drug cleared for US launchReuters
Jetrea Approved to Treat Eye ConditionU.S. News & World Report
Jetrea (Ocriplasmin) Approved For Symptomatic Vitreomacular Adhesion In The ...Medical News Today
FDA.gov -Genetic Engineering News -Pharmaceutical Business Review
all 48 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More